Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Minami

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Therapeutic Advances in Hematology|April 17, 2024
Advancements in minimal residual disease detection: a practical approach using single-cell droplet PCR for comprehensive monitoring in hematological malignancySatoshi Uchiyama, Kentaro Fukushima, Seiichiro Katagiri, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 27, 2022
Patients with B-cell malignancies experience reduced antibody responses with class switching defect following BNT162b2 SARS-CoV-2 vaccinationYu Nakagama, Sung-Gi Chi, Yosuke Minami, et al.
Case Reports in Hematology|June 29, 2026
Molecular Relapse After a Second Treatment-Free Remission Attempt Following Asciminib in Chronic Myeloid Leukemia: A Case ReportNobue Sato, Ryo Yoshimaru, Yong-Mei Guo, et al.
Plos One|October 8, 2013
Functionally deregulated AML1/RUNX1 cooperates with BCR-ABL to induce a blastic phase-like phenotype of chronic myelogenous leukemia in miceKiyoko Yamamoto, Shinobu Tsuzuki, Yosuke Minami, et al.
Cancer Science|July 28, 2016
Small-molecule Hedgehog inhibitor attenuates the leukemia-initiation potential of acute myeloid leukemia cellsNobuaki Fukushima, Yosuke Minami, Seiji Kakiuchi, et al.
Oncotargets and Therapy|July 19, 2023
Gilteritinib Affects the Selection of Dominant Clones in Clonal Hematopoiesis: Sequential Genetic Analysis of an <i>FLT3</i>-ITD Positive AML Patient with Long-Term Gilteritinib TherapySeiichiro Katagiri, Nahoko Furuya, Daigo Akahane, et al.
Asian Journal of Endoscopic Surgery|September 21, 2025
Suprapubic Open and Single-Port Laparoscopic Surgery for Urachal Remnant in Children: A Case SeriesKazuaki Takiguchi, Yosuke Minami, Seiya Ogata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2013
Combination of ponatinib with Hedgehog antagonist vismodegib for therapy-resistant BCR-ABL1-positive leukemiaSeiichiro Katagiri, Tetsuzo Tauchi, Seiichi Okabe, et al.
International Journal of Hematology|August 30, 2018
Chronic myeloid leukemia stem cells and molecular target therapies for overcoming resistance and disease persistenceAi Inoue, Chiharu I Kobayashi, Haruka Shinohara, et al.
Molecular and Clinical Oncology|May 3, 2021
Brentuximab vedotin maintenance after autologous stem cell transplantation for refractory gray zone lymphoma with long-term remissionToshiki Terao, Junichiro Yuda, Nobuhiko Yamauchi, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Therapeutic Advances in Hematology|April 17, 2024
Advancements in minimal residual disease detection: a practical approach using single-cell droplet PCR for comprehensive monitoring in hematological malignancySatoshi Uchiyama, Kentaro Fukushima, Seiichiro Katagiri, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 27, 2022
Patients with B-cell malignancies experience reduced antibody responses with class switching defect following BNT162b2 SARS-CoV-2 vaccinationYu Nakagama, Sung-Gi Chi, Yosuke Minami, et al.
Case Reports in Hematology|June 29, 2026
Molecular Relapse After a Second Treatment-Free Remission Attempt Following Asciminib in Chronic Myeloid Leukemia: A Case ReportNobue Sato, Ryo Yoshimaru, Yong-Mei Guo, et al.
Plos One|October 8, 2013
Functionally deregulated AML1/RUNX1 cooperates with BCR-ABL to induce a blastic phase-like phenotype of chronic myelogenous leukemia in miceKiyoko Yamamoto, Shinobu Tsuzuki, Yosuke Minami, et al.
Cancer Science|July 28, 2016
Small-molecule Hedgehog inhibitor attenuates the leukemia-initiation potential of acute myeloid leukemia cellsNobuaki Fukushima, Yosuke Minami, Seiji Kakiuchi, et al.
Oncotargets and Therapy|July 19, 2023
Gilteritinib Affects the Selection of Dominant Clones in Clonal Hematopoiesis: Sequential Genetic Analysis of an <i>FLT3</i>-ITD Positive AML Patient with Long-Term Gilteritinib TherapySeiichiro Katagiri, Nahoko Furuya, Daigo Akahane, et al.
Asian Journal of Endoscopic Surgery|September 21, 2025
Suprapubic Open and Single-Port Laparoscopic Surgery for Urachal Remnant in Children: A Case SeriesKazuaki Takiguchi, Yosuke Minami, Seiya Ogata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2013
Combination of ponatinib with Hedgehog antagonist vismodegib for therapy-resistant BCR-ABL1-positive leukemiaSeiichiro Katagiri, Tetsuzo Tauchi, Seiichi Okabe, et al.
International Journal of Hematology|August 30, 2018
Chronic myeloid leukemia stem cells and molecular target therapies for overcoming resistance and disease persistenceAi Inoue, Chiharu I Kobayashi, Haruka Shinohara, et al.
Molecular and Clinical Oncology|May 3, 2021
Brentuximab vedotin maintenance after autologous stem cell transplantation for refractory gray zone lymphoma with long-term remissionToshiki Terao, Junichiro Yuda, Nobuhiko Yamauchi, et al.
Pageof 11